(S1 (S (S (NP (NP (NN p18Ink4c)) (, ,) (CONJP (CC but) (RB not)) (NP (NN p27Kip1)) (, ,)) (VP (VBZ collaborates) (PP (IN with) (NP (NN Men1))) (S (VP (TO to) (VP (VB suppress) (NP (NN neuroendocrine) (NN organ) (NNS tumors))))))) (. .)))
(S1 (S (S (NP (NP (JJ Mutant) (NNS mice)) (VP (VBG lacking) (NP (NP (DT both) (NP (NP (JJ cyclin-dependent) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN CDK)) (-RRB- -RRB-))) (NNS inhibitors)) (NP (NP (NN p18-LRB-Ink4c-RRB-)) (CC and) (NP (NN p27-LRB-Kip1-RRB-)))))) (VP (VBP develop) (NP (NP (DT a) (NN tumor) (NN spectrum) (NN reminiscent)) (PP (IN of) (NP (JJ human) (NP (NP (JJ multiple) (JJ endocrine) (NN neoplasia)) (PRN (-LRB- -LRB-) (NP (NNS MEN)) (-RRB- -RRB-))) (NNS syndromes)))))) (. .)))
(S1 (S (S (S (VP (TO To) (VP (VB determine) (SBAR (WHADVP (WRB how)) (S (NP (NP (NN p18)) (CC and) (NP (NN p27))) (ADVP (RB genetically)) (VP (VBP interact) (PP (IN with) (NP (NP (NN Men1)) (, ,) (NP (NP (DT the) (NN tumor) (NN suppressor) (NN gene)) (VP (VBN mutated) (PP (IN in) (NP (JJ familial) (NN MEN1))))))))))))) (, ,) (NP (PRP we)) (VP (VBD characterized) (NP (NP (NP (NN p18-Men1)) (CC and) (NP (NN p27-Men1))) (JJ double) (JJ mutant) (NNS mice)))) (. .)))
(S1 (S (PP (VBN Compared) (PP (IN with) (NP (PRP$ their) (JJ corresponding) (JJ single) (JJ mutant) (NNS littermates)))) (, ,) (NP (DT the) (NN p18-LRB--/--RRB-) (: ;) (NN Men1-LRB-+/--RRB-) (NNS mice)) (VP (VBP develop) (NP (NNS tumors)) (PP (PP (IN at) (NP (DT an) (VBN accelerated) (NN rate))) (CC and) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN incidence)) (PP (IN in) (NP (NP (DT the) (NN pituitary)) (, ,) (NP (NN thyroid)) (, ,) (NP (JJ parathyroid)) (, ,) (CC and) (NP (NN pancreas)))))))) (. .)))
(S1 (S (PP (IN In) (NP (DT the) (JJ pituitary) (CC and) (JJ pancreatic) (NNS islets))) (, ,) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (DT the) (NN retinoblastoma) (-LRB- -LRB-) (NN Rb) (-RRB- -RRB-) (NN protein))) (PP (IN at) (NP (DT both) (NN CDK2) (CC and) (NN CDK4/6) (NNS sites)))) (VP (VP (VBD was) (VP (VBN increased) (PP (IN in) (NP (ADJP (ADJP (JJ p18-LRB--/--RRB-)) (CC and) (ADJP (JJ Men1-LRB-+/--RRB-))) (NNS cells))))) (CC and) (VP (VBD was) (ADVP (RB further)) (VP (VBN increased) (PP (IN in) (NP (NN p18-LRB--/--RRB-) (: ;) (NN Men1-LRB-+/--RRB-) (NNS cells)))))) (. .)))
(S1 (S (S (NP (DT The) (VBG remaining) (JJ wild-type) (NN Men1) (NN allele)) (VP (VP (VBD was) (VP (VBN lost) (PP (IN in) (NP (NP (JJS most) (NNS tumors)) (PP (IN from) (NP (JJ Men1-LRB-+/--RRB-) (NNS mice))))))) (CC but) (VP (VBD was) (VP (VBN retained) (PP (IN in) (NP (NP (JJS most) (NNS tumors)) (PP (IN from) (NP (NN p18-LRB--/--RRB-) (: ;) (NN Men1-LRB-+/--RRB-) (NNS mice))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Combined) (NNS mutations)) (PP (IN of) (NP (NP (NN p27-LRB--/--RRB-)) (CC and) (NP (NN Men1-LRB-+/--RRB-)))) (, ,) (PP (IN in) (NP (NN contrast))) (, ,)) (VP (VBD did) (RB not) (VP (VB exhibit) (NP (NP (JJ noticeable) (JJ synergistic) (NN stimulation)) (PP (IN of) (NP (NP (NN Rb) (NN kinase) (NN activity)) (, ,) (NP (NN cell) (NN proliferation)) (, ,) (CC and) (NP (NN tumor) (NN growth)))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VP (VBP demonstrate) (SBAR (IN that) (S (NP (JJ functional) (NN collaboration)) (VP (VBZ exists) (PP (IN between) (NP (NP (NN p18)) (CC and) (NP (NN Men1)))))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN Men1)) (VP (MD may) (VP (VB regulate) (NP (NP (JJ additional) (NN factor-LRB-s-RRB-)) (SBAR (WHNP (WDT that)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN p18)) (CC and) (NP (NN p27)))) (ADVP (RB differently))))))))))))) (. .)))
